Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Diffuse

Explore clinical trials studying Scleroderma, Diffuse. Study availability and eligibility vary by location and protocol.

220 public trials 51 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma, Diffuse trial results

Completed

Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis

NCT00848939

Conditions
Connective Tissue Diseases, Scleroderma, Diffuse, Scleroderma, Systemic, +3 more
Locations
  • Johns Hopkins Scleroderma Center Baltimore, Maryland, United States
  • Boston University School of Medicine Rheumatology Arthritis Center Boston, Massachusetts, United States
  • University of Michigan Scleroderma Program Ann Arbor, Michigan, United States
View Trial Details
Completed

A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma

NCT00930683

Conditions
Connective Tissue Diseases, Scleroderma, Scleroderma, Diffuse, +3 more
Locations
  • Research Site Los Angeles, California, United States
  • Boston University Boston, Massachusetts, United States
  • Research Site Ann Arbor, Michigan, United States
  • Research Site New Brunswick, New Jersey, United States
View Trial Details
Completed

Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis

NCT00764309

Conditions
Connective Tissue Diseases, Scleroderma, Scleroderma, Diffuse, +3 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Ucla Division Of Rheumatology Los Angeles, California, United States
  • University Of Connecticut Health Center Farmington, Connecticut, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 13 locations
View Trial Details
Completed

Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome

NCT00025818

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +28 more
Locations
  • Eyecare of La Jolla La Jolla, California, United States
  • UCLA Los Angeles, California, United States
  • Opticare Waterbury, Connecticut, United States
  • Brandon Eye Clinic Tampa, Florida, United States
View all 17 locations
View Trial Details
Completed

Oral Type I Collagen for Relieving Scleroderma

NCT00005675

Conditions
Connective Tissue Diseases, Scleroderma, Scleroderma, Diffuse, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of Connecticut Farmington, Connecticut, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View Trial Details
Completed

A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma

NCT01117298

Conditions
Cardiovascular Diseases, Connective Tissue Diseases, Digital Ulcers, +18 more
Locations
  • Department of Clinical Immunology, Army R&R hospital New Delhi, ND, India
  • Medicine Unit II, PGIMER Chandigarh, Punjab, India
  • Department of Immunology, SGPGIMS Lucknow, Uttar Pradesh, India
  • Immunology Rheumatology Unit, IPGMER Kolkata, West Bengal, India
View Trial Details

Related conditions